Search in:

Advanced search

International Journal of Nanomedicine Volume 12, 2017 - Issue

Submit an article Journal homepage

Open access

114

Views

CrossRef citations to date

Altmetric

Original Research

Polymer–lipid hybrid anti-HER2 nanoparticles for targeted salinomycin delivery to HER2-positive breast cancer stem cells and cancer cells

Jun Li1 College of Pharmacy, Liaocheng University, Liaocheng, ShandongCorrespondence[email protected]

Wenqing Xu2 Railway Police College, Zhengzhou

Xiaoli Yuan3 Department of Cadre Health Care, Nanjing General Hospital of Nanjing Military Command, Nanjing, Jiangsu

Huaiwen Chen3 Department of Cadre Health Care, Nanjing General Hospital of Nanjing Military Command, Nanjing, Jiangsu

Hao Song1 College of Pharmacy, Liaocheng University, Liaocheng, Shandong;4 Centre for Stem Cell & Regenerative Medicine, Liaocheng People’s Hospital

Bingquan Wang5 Institute of Biopharmaceutical Research, Liaocheng University, Liaocheng, Shandong, China

Jun Han5 Institute of Biopharmaceutical Research, Liaocheng University, Liaocheng, Shandong, ChinaCorrespondence[email protected]

show all

Pages 6909-6921 | Published online: 18 Sep 2017

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

BensonJRJatoiIThe global breast cancer burdenFuture Oncol20128669770222764767
PubMed Web of Science ®Google Scholar
FerlayJHéryCAutierPSankaranarayananRBreast cancer epidemiologyLiCGlobal Burden of Breast Cancer12New YorkSpringer2010119
Google Scholar
Gonzalez-AnguloAMMorales-VasquezFHortobagyiGNOverview of resistance to systemic therapy in patients with breast cancerAdv Exp Med Biol2007608112217993229
PubMedGoogle Scholar
ScullyOJBayBHYipGYuYBreast cancer metastasisCancer Genomics Proteomics20129531132022990110
PubMed Web of Science ®Google Scholar
ReyaTMorrisonSJClarkeMFWeissmanILStem cells, cancer, and cancer stem cellsNature2001414685910511111689955
PubMed Web of Science ®Google Scholar
KaiKArimaYKamiyaTSayaHBreast cancer stem cellsBreast Cancer2010172808519806428
PubMedGoogle Scholar
GuptaPBOnderTTJiangGIdentification of selective inhibitors of cancer stem cells by high-throughput screeningCell2009138464565919682730
PubMed Web of Science ®Google Scholar
MagnificoAAlbanoLCampanerSTumor-initiating cells of HER2-positive carcinoma cell lines express the highest oncoprotein levels and are sensitive to trastuzumabClin Cancer Res20091562010202119276287
PubMed Web of Science ®Google Scholar
NaujokatCSteinhartRSalinomycin as a drug for targeting human cancer stem cellsJ Biomed Biotechnol20122012895065823251084
PubMedGoogle Scholar
YueWHamaïATonelliGInhibition of the autophagic flux by salinomycin in breast cancer stem-like/progenitor cells interferes with their maintenanceAutophagy20139571472923519090
PubMed Web of Science ®Google Scholar
MeachamCEMorrisonSJTumour heterogeneity and cancer cell plasticityNature2013501746732833724048065
PubMed Web of Science ®Google Scholar
ChafferCLBrueckmannIScheelCNormal and neoplastic nonstem cells can spontaneously convert to a stem-like stateProc Natl Acad Sci U S A2011108197950795521498687
PubMed Web of Science ®Google Scholar
MaoXLiuJGongZiRGD-conjugated DSPE-PEG2000 nanomicelles for targeted delivery of salinomycin for treatment of both liver cancer cells and cancer stem cellsNanomedicine (Lond)201510172677269526355733
PubMedGoogle Scholar
XieFZhangSLiuJCodelivery of salinomycin and chloroquine by liposomes enables synergistic antitumor activity in vitroNanomedicine (Lond)201611141831184627391366
PubMed Web of Science ®Google Scholar
KrishnamurthySNgVWGaoSTanMHHedrickJLYangYYCodelivery of dual drugs from polymeric micelles for simultaneous targeting of both cancer cells and cancer stem cellsNanomedicine (Lond)201510182819283226377155
PubMedGoogle Scholar
Brannon-PeppasLBlanchetteJONanoparticle and targeted systems for cancer therapyAdv Drug Deliv Rev20126411206212
Google Scholar
ChoiHSLiuWLiuFDesign considerations for tumour-targeted nanoparticlesNat Nanotechnol201051424719893516
PubMed Web of Science ®Google Scholar
GaoJFengSSGuoYAntibody engineering promotes nanomedicine for cancer treatmentNanomedicine (Lond)2010581141114521039191
PubMedGoogle Scholar
GaoJXiaYChenHPolymer-lipid hybrid nanoparticles conjugated anti-HER2 antibody for targeted drug delivery to hepatocellular carcinomaNanomedicine (Lond)20149227929323721168
PubMed Web of Science ®Google Scholar
YardenYBiology of HER2 and its importance in breast cancerOncology2001612 suppl113
PubMedGoogle Scholar
HerbstRSReview of epidermal growth factor receptor biologyInt J Radiat Oncol Biol Phys2004592 suppl2126
PubMed Web of Science ®Google Scholar
LiuSWichaMSTargeting breast cancer stem cellsJ Clin Oncol201028254006401220498387
PubMedGoogle Scholar
GaoJChenHSongHAntibody-targeted immunoliposomes for cancer treatmentMini Rev Med Chem201313142026203524251805
PubMed Web of Science ®Google Scholar
ChanJMZhangLYuetKPPLGA-lecithin-PEG core-shell nanoparticles for controlled drug deliveryBiomaterials20093081627163419111339
PubMed Web of Science ®Google Scholar
GaoJLiWGuoYFengSSNanomedicine strategies for sustained, controlled and targeted treatment of cancer stem cellsNanomedicine (Lond)201611243261328227854161
PubMedGoogle Scholar
Charafe-JauffretEGinestierCIovinoFAldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancerClin Cancer Res2010161455520028757
PubMed Web of Science ®Google Scholar
GaoJKouGWangHPE38KDEL-loaded anti-HER2 nanoparticles inhibit breast tumor progression with reduced toxicity and immunogenicityBreast Cancer Res Treat20091151294118481173
PubMed Web of Science ®Google Scholar
GaoJSunJLiHLyophilized HER2-specific PEGylated immunoliposomes for active siRNA gene silencingBiomaterials20103192655266420035999
PubMed Web of Science ®Google Scholar
AiJBiazarEJafarpourMNanotoxicology and nanoparticle safety in biomedical designsInt J Nanomedicine201161117112721698080
PubMedGoogle Scholar
GaoJGuoYFengSSNanomedicine for treatment of cancer stem cellsNanomedicine (Lond)20149218118424552558
PubMedGoogle Scholar
WangCHChiouSHChouCPChenYCHuangYJPengCAPhotothermolysis of glioblastoma stem-like cells targeted by carbon nanotubes conjugated with CD133 monoclonal antibodyNanomedicine201171697920620237
PubMed Web of Science ®Google Scholar
KorkayaHPaulsonAIovinoFWichaMSHER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasionOncogene200827476120613018591932
PubMedGoogle Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Polymer–lipid hybrid anti-HER2 nanoparticles for targeted salinomycin delivery to HER2-positive breast cancer stem cells and cancer cells

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Polymer–lipid hybrid anti-HER2 nanoparticles for targeted salinomycin delivery to HER2-positive breast cancer stem cells and cancer cells

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date